{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T22:21:45Z","timestamp":1781648505604,"version":"3.54.5"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.4158\/ep12064.or","type":"journal-article","created":{"date-parts":[[2012,7,11]],"date-time":"2012-07-11T21:05:28Z","timestamp":1342040728000},"page":"826-833","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Reduction of Insulin Resistance and Plasma Glucose Level by Salsalate Treatment in Persons With Prediabetes"],"prefix":"10.1016","volume":"18","author":[{"given":"Elham","family":"Faghihimani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashraf","family":"Aminorroaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Rezvanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peyman","family":"Adibi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faramarz","family":"Ismail-Beigi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masoud","family":"Amini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP12064.OR_bb0010","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.mcna.2010.11.003","article-title":"Epidemiology of prediabetes","volume":"95","author":"Colagiuri","year":"2011","journal-title":"Med Clin North Am"},{"key":"10.4158\/EP12064.OR_bb0015","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1742-1241.2008.01705.x","article-title":"Prediabetes: a must to recognise disease state","volume":"62","author":"Eldin","year":"2008","journal-title":"Int J Clin Pract"},{"key":"10.4158\/EP12064.OR_bb0020","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S1098-3597(09)62039-1","article-title":"Identification and treatment of prediabetes to prevent progression to type 2 diabetes","volume":"9","author":"Fonseca","year":"2008","journal-title":"Clin Cornerstone"},{"key":"10.4158\/EP12064.OR_bb0025","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.2337\/diabetes.53.suppl_3.S34","article-title":"Prevention of type 2 diabetes: insulin resistance and beta-cell function","volume":"53","author":"Chiasson","year":"2004","journal-title":"Diabetes"},{"key":"10.4158\/EP12064.OR_bb0030","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1038\/nm1185","article-title":"IKK-beta links inflammation to obesity-induced insulin resistance","volume":"11","author":"Arkan","year":"2005","journal-title":"Nat Med"},{"key":"10.4158\/EP12064.OR_bb0035","doi-asserted-by":"crossref","first-page":"137","DOI":"10.4093\/kdj.2010.34.3.137","article-title":"Inflammation and insulin resistance: an old story with new ideas","volume":"34","author":"Kim","year":"2010","journal-title":"Korean Diabetes J"},{"key":"10.4158\/EP12064.OR_bb0040","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1038\/sj.ijo.0802501","article-title":"Inflammation and the IKK beta\/I kappa B\/NF-kappa B axis in obesity- and diet-induced insulin resistance","volume":"27","author":"Shoelson","year":"2003","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.4158\/EP12064.OR_bb0045","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00125-008-1239-x","article-title":"The effect of salsalate on insulin action and glucose tolerance in obese non-diabetic patients: results of a randomised double-blind placebo-controlled study","volume":"52","author":"Koska","year":"2009","journal-title":"Diabetologia"},{"key":"10.4158\/EP12064.OR_bb0050","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1345\/aph.1M483","article-title":"Potential role of salicylates in type 2 diabetes","volume":"44","author":"Rumore","year":"2010","journal-title":"Ann Pharmacother"},{"key":"10.4158\/EP12064.OR_bb0055","doi-asserted-by":"crossref","first-page":"346","DOI":"10.7326\/0003-4819-152-6-201003160-00004","article-title":"The effects of salsalate on glycemic control in patients with type 2 diabetes: a randomized trial","volume":"152","author":"Goldfine","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.4158\/EP12064.OR_bb0060","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1126\/science.1061620","article-title":"Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta","volume":"293","author":"Yuan","year":"2001","journal-title":"Science"},{"key":"10.4158\/EP12064.OR_bb0065","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.8052854","article-title":"Inhibition of NF-kappa B by sodium salicylate and aspirin","volume":"265","author":"Kopp","year":"1994","journal-title":"Science"},{"key":"10.4158\/EP12064.OR_bb0070","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nm1166","article-title":"Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB","volume":"11","author":"Cai","year":"2005","journal-title":"Nat Med"},{"issue":"suppl 1","key":"10.4158\/EP12064.OR_bb0075","doi-asserted-by":"crossref","first-page":"S62","DOI":"10.2337\/dc10-S062","article-title":"Diagnosis and classification of diabetes mellitus [published correction appears in 33:e57]. Diabetes Care. 2010","volume":"33","author":"American Diabetes Association","year":"2010","journal-title":"Diabetes Care."},{"key":"10.4158\/EP12064.OR_bb0080","first-page":"1","article-title":"Physical status: the use and interpretation of anthropometry; report of a WHO Expert Committee.","volume":"854","author":"WHO Expert Committee","year":"1995","journal-title":"World Health Organ Tech Rep Ser."},{"key":"10.4158\/EP12064.OR_bb0085","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.4158\/EP12064.OR_bb0090","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","article-title":"Use and abuse of HOMA modeling","volume":"27","author":"Wallace","year":"2004","journal-title":"Diabetes Care"},{"key":"10.4158\/EP12064.OR_bb0095","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1172\/JCI29069","article-title":"Inflammation and insulin resistance","volume":"116","author":"Shoelson","year":"2006","journal-title":"J Clin Invest"},{"key":"10.4158\/EP12064.OR_bb0100","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/bmj.39063.689375.55","article-title":"Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis","volume":"334","author":"Gillies","year":"2007","journal-title":"BMJ"},{"key":"10.4158\/EP12064.OR_bb0105","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2119\/2007-00119.Tilg","article-title":"Inflammatory mechanisms in the regulation of insulin resistance","volume":"14","author":"Tilg","year":"2008","journal-title":"Mol Med"},{"key":"10.4158\/EP12064.OR_bb0110","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.2337\/dc08-zb07","article-title":"Approaches to treatment of pre-diabetes and obesity and promising new approaches to type 2 diabetes","volume":"31","author":"Bloomgarden","year":"2008","journal-title":"Diabetes Care"},{"key":"10.4158\/EP12064.OR_bb0115","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2337\/dc07-1338","article-title":"Salsalate improves glycemia and inflammatory parameters in obese young adults","volume":"31","author":"Fleischman","year":"2008","journal-title":"Diabetes Care"},{"key":"10.4158\/EP12064.OR_bb0120","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1172\/JCI11559","article-title":"Prevention of fat-induced insulin resistance by salicylate","volume":"108","author":"Kim","year":"2001","journal-title":"J Clin Invest"},{"key":"10.4158\/EP12064.OR_bb0125","unstructured":"Faghihimani E, Aminorroaya A, Rezvanian H, Adibi P, Ismail-Beigi F, Amini M. Salsalate improves glycemic control in patients with newly diagnosed type 2 diabetes [published online ahead of print September 22, 2011]. Acta Diabetol. PMID: 21938543."},{"key":"10.4158\/EP12064.OR_bb0130","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.amjmed.2005.05.018","article-title":"Diabetes, prediabetes, and cardiovascular risk: shifting the paradigm","volume":"118","author":"Deedwania","year":"2005","journal-title":"Am J Med"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20430137?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20430137?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/aace.metapress.com\/index\/F183063G6168K358.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:54:06Z","timestamp":1761515646000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20430137"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S1530891X20430137"],"URL":"https:\/\/doi.org\/10.4158\/ep12064.or","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reduction of Insulin Resistance and Plasma Glucose Level by Salsalate Treatment in Persons With Prediabetes","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP12064.OR","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}